As per attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 2.9 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vipul Organics reported audited standalone FY25 revenue of Rs. 162.80 crore, up ~8.5% from Rs. 150.08 crore in FY24. Standalone profit after tax rose ~34% to ~Rs. 4.80 crore (from Rs. 3.58 crore), with EPS at Rs. 2.71 vs Rs. 2.09. Q4 FY25 revenue grew ~10% YoY to Rs. 44.09 crore, though Q4 standalone PAT dipped to Rs. 0.75 crore from Rs. 1.07 crore. The Board recommended an 8% dividend (Re. 0.80 per share) pending shareholder approval. Statutory auditor J.A. Rajani & Co. issued an unmodified (clean) opinion. A new Secretarial Auditor (T.F. Khatri & Associates) was appointed for FY26, and a Rs. 20.34 crore rights issue (42.37 lakh shares at Rs. 48/share) was completed on April 8, 2025. Operating cash flow shrank sharply to just Rs. 62 lakh (vs Rs. 486 lakh in FY24).
Full-year profit growth above 25% and a dividend declaration are positives for shareholders, while a ~34% jump in trade receivables and weak operating cash flow despite higher profits, along with the dilutive rights issue, are points to watch for the stock price.